Literature DB >> 2642443

Ulcers, nonsteroidal antiinflammatory drugs, and related matters.

A H Soll1, J Kurata, J E McGuigan.   

Abstract

This overview is intended to provide perspectives drawn from the proceedings of the Ulcer-Epidemiology Symposium reported in this supplement. This meeting was designed to review the epidemiology and risk factors underlying the development of acid/peptic diseases and to highlight the natural history and therapy of these disorders. These topics served as a focus for the meeting. A second goal was to consider the topics in the context of ulcer complications resulting from use of nonsteroidal antiinflammatory drugs. Although nonsteroidal antiinflammatory drugs are well known to cause gastric damage and ulcers and to lead to complications of preexisting peptic ulcers, the frequency and severity of the clinical problems resulting from their use and the efficacy of different modalities for prevention and treatment have only recently begun to be the subjects of careful analysis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2642443     DOI: 10.1016/s0016-5085(89)80051-4

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  12 in total

Review 1.  Gastrointestinal complications of nonsteroidal anti-inflammatory drugs.

Authors:  R R Babb
Journal:  West J Med       Date:  1992-10

Review 2.  NSAID-induced gastrointestinal damage. Epidemiology, risk and prevention, with an evaluation of the role of misoprostol. An Asia-Pacific perspective and consensus.

Authors:  G D Champion; P H Feng; T Azuma; D E Caughey; K H Chan; S Kashiwazaki; H C Liu; A R Nasution; M Nobunaga; S Prichanond; T P Torralba; V Udom; D Utis; S R Wang; W S Wong; D J Yang; M C Yoo
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

3.  Potentiating effect of passive cigarette smoking on gastrointestinal damage induced by indomethacin in rats.

Authors:  X Guo; Q B Mei; C H Cho
Journal:  Dig Dis Sci       Date:  1999-05       Impact factor: 3.199

4.  Prostaglandin E2 production by dispersed canine fundic mucosal cells. Contribution of macrophages and endothelial cells as major sources.

Authors:  M C Chen; M J Sanders; D A Amirian; L P Thomas; G Kauffman; A H Soll
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

5.  Aspirin potentiates prestimulated acid secretion and mobilizes intracellular calcium in rabbit parietal cells.

Authors:  R A Levine; J Nandi; R L King
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

6.  Cyclooxygenase inhibition with indomethacin increases human duodenal mucosal response to prostaglandin E1.

Authors:  D L Hogan; M A Ballesteros; M A Koss; J I Isenberg
Journal:  Dig Dis Sci       Date:  1989-12       Impact factor: 3.199

Review 7.  Optimal management of gout in older patients.

Authors:  E B Gonzalez; S B Miller; C A Agudelo
Journal:  Drugs Aging       Date:  1994-02       Impact factor: 3.923

8.  Effect of difluoromethylornithine (DFMO) on NSAID-induced intestinal injury in rats.

Authors:  R A Erickson; N Rivera
Journal:  Dig Dis Sci       Date:  1992-12       Impact factor: 3.199

Review 9.  Pharmacokinetic optimisation of the treatment of peptic ulcer in patients with renal failure.

Authors:  U Gladziwa; U Koltz
Journal:  Clin Pharmacokinet       Date:  1994-11       Impact factor: 6.447

Review 10.  Helicobacter pylori infection as a cause of gastritis, duodenal ulcer, gastric cancer and nonulcer dyspepsia: a systematic overview.

Authors:  S J Veldhuyzen van Zanten; P M Sherman
Journal:  CMAJ       Date:  1994-01-15       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.